APA (7th ed.) Citation

Fitchett, D., Inzucchi, S. E., Zinman, B., Wanner, C., Schumacher, M., Schmoor, C., . . . Zannad, F. (2021). Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA‐REG OUTCOME trial. ESC Heart Failure, 8(6), 4517-4527. https://doi.org/10.1002/ehf2.13615

Chicago Style (17th ed.) Citation

Fitchett, David, et al. "Mediators of the Improvement in Heart Failure Outcomes with Empagliflozin in the EMPA‐REG OUTCOME Trial." ESC Heart Failure 8, no. 6 (2021): 4517-4527. https://doi.org/10.1002/ehf2.13615.

MLA (9th ed.) Citation

Fitchett, David, et al. "Mediators of the Improvement in Heart Failure Outcomes with Empagliflozin in the EMPA‐REG OUTCOME Trial." ESC Heart Failure, vol. 8, no. 6, 2021, pp. 4517-4527, https://doi.org/10.1002/ehf2.13615.